A Global Cross-Sectional Database Study of Low Dose FVIII SHL Prophylaxis in Haemophilia A

CONCLUSION: Underrepresentation of low-resource countries in WAPPS-Hemo underscores the financial challenges in haemophilia treatment. The association between GNI/UHCI and P(LDP) suggests cost-driven adoption of LDP in low-resource settings, especially in children. PK outcomes average similarities may facilitate LDP-usage in WAPPS-Hemo.